SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-382958
Filing Date
2015-11-20
Accepted
2015-11-20 08:50:00
Documents
10
Period of Report
2015-11-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d214933d8k.htm 8-K 24134
2 EX-4.1 d214933dex41.htm EX-4.1 78440
3 EX-5.1 d214933dex51.htm EX-5.1 10583
4 EX-10.1 d214933dex101.htm EX-10.1 210598
5 EX-10.2 d214933dex102.htm EX-10.2 89669
6 EX-10.3 d214933dex103.htm EX-10.3 119205
7 EX-99.1 d214933dex991.htm EX-99.1 8044
8 GRAPHIC g214933g40m18.jpg GRAPHIC 4914
9 GRAPHIC g214933g67e93.jpg GRAPHIC 2793
10 GRAPHIC g214933g91y17.jpg GRAPHIC 3104
  Complete submission text file 0001193125-15-382958.txt   557360
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 151245042
SIC: 2834 Pharmaceutical Preparations